Cargando…
Advances in sarcoma diagnostics and treatment
The heterogeneity of sarcomas with regard to molecular genesis, histology, clinical characteristics, and response to treatment makes management of these rare yet diverse neoplasms particularly challenging. This review encompasses recent developments in sarcoma diagnostics and treatment, including cy...
Autores principales: | Dancsok, Amanda R, Asleh-Aburaya, Karama, Nielsen, Torsten O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351692/ https://www.ncbi.nlm.nih.gov/pubmed/27732970 http://dx.doi.org/10.18632/oncotarget.12548 |
Ejemplares similares
-
Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
por: Asleh, Karama, et al.
Publicado: (2022) -
Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience
por: Asleh-Aburaya, Karama, et al.
Publicado: (2015) -
Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas
por: Dancsok, Amanda R., et al.
Publicado: (2020) -
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
por: Stovgaard, Elisabeth S, et al.
Publicado: (2021) -
Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer
por: Asleh, Karama, et al.
Publicado: (2021)